Empyrean Protocol

Empyrean Intelligence Console

← Back to briefs

AXA France IARD SA v Santander Cards UK Ltd [2025] EWHC 1881 (Comm) (25 July 2025)

Source: Open mirrored case · Original bailii.org

Sanctions ✓ Geo ✓

Executive Summary

  • The 2025 High Court judgment in *AXA France IARD SA v Santander Cards UK Ltd* addresses liability for mis-selling pre-2005 Payment Protection Insurance (PPI) policies.
  • AXA claims Santander agreed in a 2015 Settlement Agreement to handle all related complaints and redress, or alternatively, indemnify AXA under a 2000 Agency Agreement.
  • The court examined whether Santander is liable for mis-selling breaches under the ABI Code and the scope of indemnity, contribution, and negligence claims.
  • The trial focused on the contractual and regulatory relationship between AXA’s predecessors (FICL/FACL) and Santander’s predecessors (GECB), including commission structures and regulatory compliance.

Sanctions Highlights

  • The case implicates sanctions compliance due to references to BIS (UK’s Department for Business, Innovation and Skills) and sanction regimes governing insurance and financial services.
  • Regulatory frameworks such as FSMA and ABI Codes impose strict conduct requirements, with potential sanctions for breaches in mis-selling practices.
  • The judgment underscores the importance of adherence to sanctions and regulatory codes in cross-border insurance dealings involving France, UK, and US entities.

Emerging Risks

  • Potential liability exposure for insurers and intermediaries in legacy PPI mis-selling claims remains significant, especially where indemnity agreements or settlement clauses are ambiguous.
  • Risk of regulatory sanctions and reputational damage persists if firms fail to meet evolving standards of disclosure and customer suitability under ABI and FSMA frameworks.
  • The complexity of commission and claims fund arrangements between insurers and intermediaries may create financial and legal risks in future disputes.

Geopolitical Impact

  • The case involves major financial institutions from France (AXA) and the UK (Santander), highlighting cross-jurisdictional regulatory challenges.
  • UK regulatory standards (ABI Code, FSMA) and enforcement mechanisms influence French insurers operating in the UK market.
  • The involvement of US legal counsel and references to US sanctions frameworks reflect the transatlantic dimension of financial regulation and compliance.
  • Outcomes may influence regulatory cooperation and enforcement approaches among France, UK, and US authorities in insurance and financial services sectors.

Economic Intelligence

  • The dispute centers on financial liabilities arising from PPI mis-selling, with significant sums potentially payable by Santander to AXA for customer redress, fees, and administrative costs.
  • Commission structures detailed (50-70% upfront to intermediaries, 25-40% retained for claims funds) affect profit margins and risk-sharing between insurers and intermediaries.
  • Insurance Premium Tax (IPT) at 2% is a minor but relevant fiscal consideration in the overall financial arrangements.
  • The case may set precedent affecting future insurance product sales, claims handling, and indemnity arrangements, impacting market stability and insurer profitability.

Strategic Recommendations

  • Insurers and intermediaries should rigorously review legacy agreements and settlement terms to clarify indemnity and liability scopes.
  • Compliance programs must be enhanced to ensure adherence to ABI Codes, FSMA, and applicable sanctions regimes, minimizing regulatory and litigation risks.
  • Cross-border regulatory coordination should be prioritized to manage geopolitical complexities in insurance disputes involving multinational parties.
  • Financial institutions should reassess commission and claims fund models to ensure transparency and equitable risk allocation.
  • Legal teams should monitor evolving case law on PPI mis-selling and related indemnity claims to anticipate and mitigate emerging liabilities.

---

**Source Notes:** *Sanctions Intelligence Digest*, [https://empyreanprotocol.com/litigation/view/www.bailii.org/ew/cases/EWHC/Comm/2025/1881.html](https://empyreanprotocol.com/litigation/view/www.bailii.org/ew/cases/EWHC/Comm/2025/1881.html)

Brief metadata